glp 1 ra Comprehensive Overview of GLP-1 RAs in Cardiometabolic Care Emerging Trends in the Development

In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report

For tirzepatide, 503A (traditional) pharmacies had until February 18, 2025, and 503B (outsourcing) facilities had until March 19, 2025 to stop their GLP-1 production

Allowing manufacturers to list device patents in the Orange Book can delay generic competition by giving brand-name firms an opportunity to file litigation and earn 30-month stays even when patents are not infringed by the generic product

The story of obesity in 2026 is not a story about weight

For diabetic retinopathy, the evidence was nuanced, indicating potential long-term neurovascular protection but also a risk of transient early worsening